Fauna Bio
Berkeley
About Fauna Bio
Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Funding stage: Seed
- Last round: Seed (Sep 2021)
- Website: faunabio.com
Industries & Categories
Biotechnology, Health Care, Hospital, Medical
Social Profiles
Canonical: https://fsome.com/organization/fauna-bio-15000 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.